Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis
- 1 June 1992
- journal article
- Published by Elsevier BV in Virology
- Vol. 188 (2), 900-904
- https://doi.org/10.1016/0042-6822(92)90550-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- In Vivo Prevalence of Azidothymidine (AZT) Resistance Mutations in an AIDS Patient Before and After AZT TherapyAIDS Research and Human Retroviruses, 1991
- A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding siteBiochemistry, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- HIV-1 Reverse Transcriptase: Structure Predictions for the Polymerase DomainAIDS Research and Human Retroviruses, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- Effects of small insertions on the RNA-dependent DNA polymerase activity of HIV-1 reverse transcriptaseVirology, 1989
- Site-specific mutagenesis of AIDS virus reverse transcriptaseNature, 1987
- Genome organization and transactivation of the human immunodeficiency virus type 2Nature, 1987